PACS Group (NYSE:PACS) Stock Keeps “Buy” Rating at Truist Financial

PACS Group (NYSE:PACS)‘s stock had its “buy” rating reissued by analysts at Truist Financial in a research note issued to investors on Thursday, Benzinga reports. They currently have a $65.00 target price on the stock, up from their prior target price of $62.00. Truist Financial‘s price target points to a potential upside of 27.23% from the stock’s previous close.

A number of other research firms have also commented on PACS. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. JPMorgan Chase & Co. increased their price target on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Stephens lifted their price objective on PACS Group from $60.00 to $64.00 and gave the stock an “overweight” rating in a research report on Thursday. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, UBS Group lifted their price objective on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, PACS Group currently has an average rating of “Moderate Buy” and an average target price of $60.17.

PACS Group Stock Up 1.7%

Shares of NYSE:PACS traded up $0.83 during midday trading on Thursday, reaching $51.09. 143,726 shares of the company were exchanged, compared to its average volume of 892,278. The stock has a fifty day simple moving average of $44.42 and a two-hundred day simple moving average of $39.91. The firm has a market cap of $8.09 billion, a PE ratio of 28.87, a P/E/G ratio of 1.46 and a beta of -0.14. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group has a fifty-two week low of $10.31 and a fifty-two week high of $51.68.

PACS Group (NYSE:PACS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 33.39%. As a group, sell-side analysts forecast that PACS Group will post 2.13 earnings per share for the current year.

Insider Buying and Selling

In other PACS Group news, Director Mark Hancock sold 186,696 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the sale, the director owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the transaction, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at approximately $2,710,654,034.24. This trade represents a 0.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,762,431 shares of company stock valued at $80,686,053 over the last quarter. 70.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On PACS Group

A number of institutional investors have recently made changes to their positions in PACS. Dimensional Fund Advisors LP grew its stake in shares of PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares during the last quarter. Sei Investments Co. lifted its position in PACS Group by 7.4% during the first quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after purchasing an additional 25,462 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of PACS Group by 44.6% in the first quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after purchasing an additional 89,067 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of PACS Group in the second quarter valued at about $8,196,000. Finally, Corient Private Wealth LP grew its holdings in PACS Group by 1.8% during the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company’s stock valued at $6,517,000 after buying an additional 2,680 shares in the last quarter.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS delivered a strong third quarter: earnings were $0.63 per share versus estimates of $0.56–$0.58, and revenue of $1.50 billion topped the $1.46 billion consensus. Adjusted EBITDA rose 33.6%, with the article attributing growth to maturing nursing facilities. PACS Group Q3 2026 earnings
• Positive Sentiment: The company raised its 2026 outlook to $5.95–$6.05 billion in revenue and $685–$695 million in adjusted EBITDA. The upgraded forecast supports expectations for continued operating growth. PACS raises 2026 outlook
• Positive Sentiment: PACS leaders highlighted acquisitions in Florida and Texas and occupancy near 90%, signaling expansion and healthy facility demand. An aging population and limited new senior-housing construction may also support the sector’s long-term demand backdrop. PACS acquisitions and occupancy
• Negative Sentiment: CEO Jason Murray, director Mark Hancock, and CAO Michelle Lewis disclosed stock sales. The transactions were made under pre-arranged Rule 10b5-1 plans, and the executives retained substantial holdings, which may limit the signal’s significance. PACS insider sales

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.